France-Israel: 4P-Pharma, SATT Aquitaine and Bordeaux University to develop an anti-cancer drug. Video
4P-Pharma has signed an exclusive license agreement with Aquitaine Science Transfert, for the development of a drug targeting pancreatic cancer, triple negative breast cancer or colon cancer. The molecule was first developed and patented by researchers from the laboratory of…